VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors
Clinical trial NCT02164838 · COMPLETED
Trial details
- NCT number
- NCT02164838
- Sponsor
- Children's Oncology Group
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2017-10-19
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.